Applied DNA Reports 2019 Year End and Fiscal Fourth Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Applied DNA Sciences (APDN) Misses Q4 EPS by 18c, Revenues Miss
December 12, 2019 4:15 PM ESTApplied DNA Sciences (NASDAQ: APDN) reported Q4 EPS of ($1.44), $0.18 worse than the analyst estimate of ($1.26). Revenue for the quarter came in at $1.7 thousand versus the consensus estimate of $2.11 million.
Fiscal Fourth Quarter 2019 Financial Results:
Revenues increased 40% for the fourth quarter of fiscal 2019 to $1.7 million, compared with $1.2 million reported in the same period of the prior fiscal year and decreased 19% from $2.1 million for the third quarter of fiscal 2019. The increase in revenues year over year was due primarily to an increase in product revenues from shipments of DNA concentrate to protect... More